| [1] |
WU JY, SUN JX, WU JY, et al. A nomogram based on combining systemic and hepatic inflammation markers for predicting microscopic bile duct tumour thrombus in hepatocellular carcinoma[J]. BMC Cancer, 2021, 21(1): 272. DOI: 10.1186/s12885-021-07956-9. |
| [2] |
KIM DS, KIM BW, HATANO E, et al. Surgical outcomes of hepatocellular carcinoma with bile duct tumor thrombus: A Korea-Japan multicenter study[J]. Ann Surg, 2020, 271(5): 913-921. DOI: 10.1097/SLA.0000000000003014. |
| [3] |
LLOVET JM, KELLEY RK, VILLANUEVA A, et al. Hepatocellular carcinoma[J]. Nat Rev Dis Primers, 2021, 7(1): 6. DOI: 10.1038/s41572-020-00240-3. |
| [4] |
LU WP, TANG HW, YANG ZY, et al. A proposed modification for the Barcelona Clinic Liver Cancer staging system: Adding bile duct tumor thrombus status in patients with hepatocellular carcinoma[J]. Am J Surg, 2020, 220(4): 965-971. DOI: 10.1016/j.amjsurg.2020.04.003. |
| [5] |
WU JY, SUN JX, WU JY, et al. Impact of bile duct tumor thrombus on the long-term surgical outcomes of hepatocellular carcinoma patients: A propensity score matching analysis[J]. Ann Surg Oncol, 2022, 29(2): 949-958. DOI: 10.1245/s10434-021-10799-0. |
| [6] |
WU Z, GUO K, SUN H, et al. Caution for diagnosis and surgical treatment of recurrent cholangitis: lessons from 5 cases of bile duct tumor thrombus without a detectable intrahepatic tumor[J]. Medicine (Baltimore), 2014, 93(11): e80. DOI: 10.1097/MD.0000000000000080. |
| [7] |
ZHOU D, HU GF, GAO WC, et al. Hepatocellular carcinoma with tumor thrombus in bile duct: A proposal of new classification according to resectability of primary lesion[J]. World J Gastroenterol, 2020, 26(44): 7005-7021. DOI: 10.3748/wjg.v26.i44.7005. |
| [8] |
LIU P, YU SJ, CHENG Y. Advances in the application of endoscopic ultrasound in the diagnosis and treatment of liver cancer[J]. J Clin Hepatol, 2021, 37(8): 1934-1937. DOI: 10.3969/j.issn.1001-5256.2021.08.041. |
| [9] |
QIN LX, TANG ZY. Hepatocellular carcinoma with obstructive jaundice: diagnosis, treatment and prognosis[J]. World J Gastroenterol, 2003, 9(3): 385-391. DOI: 10.3748/wjg.v9.i3.385. |
| [10] |
Chinese Association of Liver Cancer, Chinese Medical Doctor Association. Chinese expert consensus on multidisciplinary diagnosis and treatment of hepatocellular carcinoma with bile duct tumor thrombus (2020 edition)[J]. Chin J Dig Surg, 2021, 20(2): 135-142. DOI: 10.3760/cma.j.cn115610-20210208-00068. |
| [11] |
ZHOU X, WANG J, TANG M, et al. Hepatocellular carcinoma with hilar bile duct tumor thrombus versus hilar cholangiocarcinoma on enhanced computed tomography: a diagnostic challenge[J]. BMC Cancer, 2020, 20(1): 54. DOI: 10.1186/s12885-020-6539-7. |
| [12] |
LIU Q, CHEN J, LI H, et al. Hepatocellular carcinoma with bile duct tumor thrombi: correlation of magnetic resonance imaging features to histopathologic manifestations[J]. Eur J Radiol, 2010, 76(1): 103-109. DOI: 10.1016/j.ejrad.2009.05.020. |
| [13] |
CHI Q, SHI Z, ZHANG Z, et al. Outcomes of resection for hepatocellular carcinoma with macroscopic bile duct tumour thrombus: A propensity score matched study[J]. Oncol Lett, 2020, 20(4): 118. DOI: 10.3892/ol.2020.11979. |
| [14] |
LONG XY, LI YX, WU W, et al. Diagnosis of bile duct hepatocellular carcinoma thrombus without obvious intrahepatic mass[J]. World J Gastroenterol, 2010, 16(39): 4998-5004. DOI: 10.3748/wjg.v16.i39.4998. |
DownLoad:
